Category: Medical
Phenytoin 90mg/5ml Oral Suspension immediate discontinuation
There has been an immediate discontinuation of unlicensed medicine Phenytoin 90mg/5ml Oral Suspension and a recall of the product.
The medication, manufactured by Rosemont Pharmaceuticals Limited, is now no longer on the shelves having been recalled and discontinued with immediate affect as a result of worrying data that suggested that the medication becomes difficult to resuspend over shelf-life.
Patients who use the Phenytoin 90mg/5ml Oral Suspension are being told to contact their doctors for more information and advice about the issues that have been identified.
Roche Diabetes Care test strip errors leads to recall
Roche Diabetes Care test strip errors has led to a recall of a number of home-use and point-of-care glucose monitoring systems.
The Roche Diabetes Care test strip errors are for the following systems: Accu-Chek Aviva; Accu-Chek Performa; and Accu-Chek Inform II.
There is a risk of a strip error message that may lead to either falsely high or falsely low blood glucose results reported.
A troubling testimony in the Gosport War Memorial Hospital deaths
A troubling testimony in the Gosport War Memorial Hospital deaths has been recounted in the recent independent inquiry that deemed some 450 deaths at the hospital were linked to an unsafe opioid-use policy.
Families who have been fighting for an inquiry for years have finally received the news that they say they knew all along: that their loved-ones died in the hospital prematurely.
At the centre of the Gosport War Memorial Hospital deaths scandal is Dr Jane Barton; the GP stationed there who claims that she was only ever doing the best for her patients. One particularly troubling testimony from 2001 that was recounted in the independent report paints a different story entirely.
Gosport hospital deaths could have been avoided
According to an independent report, 450 Gosport hospital deaths could have been avoided after life-shortening opioids were reportedly given to elderly patients who did not need them.
The damning report found that a GP working at the hospital, Dr Jane Barton, routinely overprescribed drugs to patients in the 1990s, and consultants who were aware of her actions did not intervene. Further, nurses and pharmacists would have known that the high levels of opioids administered would not always have been appropriate, and they too failed to stop the deaths.
After years of the families campaigning and suffering over the Gosport hospital deaths, the report has finally confirmed what they already knew.
Diabetes testing kit recall
News of a diabetes testing kit recall is said to be “urgent” amid fears of lives at risk over false readings.
The Accu-Chek Aviva and the Accu-Chek Performa are the diabetes testing kits being recalled that could lead to an overdose or an under-dose of insulin that can lead to serious health complications for users.
Advice to patients is to stop using the affected devices and return them to a pharmacy for a replacement.
J & J subsidiary companied sued for breast implants causing cancer
A J & J subsidiary companied is reportedly being sued for breast implants causing cancer. According to the legal case, a Johnson & Johnson subsidiary company who has manufactured breast implants for some 5 million women has left at least one woman with breast cancer.
It’s alleged that the Claimant developed breast implant-associated anaplastic large-cell lymphoma, which is a rare form of T-cell lymphoma. She alleges that the cause of her cancer stems from being fitted with MemoryGel Siltex breast implants that are manufactured by Mentor Worldwide LLC; a subsidiary company of J & J.
Another J & J talcum powder asbestos cancer Claimant awarded damages
Another J & J talcum powder asbestos cancer Claimant has been awarded damages in the sum of over £15m.
The case is one of many that has run to trial, and there are thousands of Claimants who have reportedly lodged claims against pharmaceutical giants, Johnson & Johnson, on the basis that they have asbestos-induced mesothelioma caused by their talc products.
So far, millions of pounds have been awarded for J & J talc claimants, although the manufacturer and their supplier – both of whom are under fire in some of the legal cases – deny that their products are harmful.
EpiPen failures not to be ignored
Recent data surrounding reported EpiPen failures should not be ignored. Data reviewed has found that, in the last few years, there has been hundreds of reports of EpiePen failures that have led to a number of hospitalisations, and potentially some deaths.
One issue reported after a failed delivery from an EpiPen was the needle sticking out of the device at an angle, preventing delivery of lifesaving adrenaline that can stop an allergic reaction from killing someone.
Given the importance of lifesaving devices, these reported EpiPen failures cannot be ignored.
Calls for UK inquiry into sodium valproate epilepsy drug
There are calls for a UK inquiry into the sodium valproate epilepsy drug that has been linked to birth defects and developmental issues in children.
It’s also understood that UK health professionals were warned about the dangers of people using sodium valproate epilepsy drugs, but little seems to have been done – especially in the past – to ensure users were informed of the risks and were able to make decisions as to the use of the drug.
There are also questions over whether the drug should be classed as safe at all, and the HSE is reportedly looking at the issue. We may see a UK inquiry into the side-effects soon.
Group Action Lawyers contacted for help after NHS Breast Cancer Screening Scandal
The Group Action Lawyers have been contacted for help after the news broke about the NHS Breast Cancer Screening Scandal. Individuals who did not receive their invitation for breast cancer screening and have since developed breast cancer, or families of patients who have passed away because the patient was not offered screening, may be entitled to take legal action.
A computer glitch has been blamed for the error that resulted in some 450,000 women aged between 68 and 71 reportedly not receiving their invitation for breast cancer screening because a computer program is said to have had the cut-off age at 70 by mistake. What’s worse is that it has taken nine years for the problem to be identified, with the glitch occurring sometime in 2009.